Vanja Ralić

Ms. Vanja Ralić

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2025 in Inorganics
Verified
Journal Article
Open access
PDF file
Vanja RalićVanja Ralić
Vanja Ralić
MNMaja Nešić
Maja Nešić
TDTanja Ducic
Tanja Ducic
MSMilutin Stepić
Milutin Stepić
LKLela Korićanac
Lela Korićanac
MPMarijana Petkovic
Marijana Petkovic
Transition metal complexes have been used in medicine for several decades, but their intracellular effects are not yet fully elucidated. Therefore, in this study, we investigate biomolecular changes induced by a palladium(II) complex in cervical carcinoma (HeLa) cells as a model to study the subtle changes caused by transition metal ions ingested by the cells. The impact of dichloro(1,2-diaminocyclohexane)palladium(II), [Pd(dach)Cl2], was studied by synchrotron radiation-based Fourier transform infrared (SR FTIR) spectroscopy, a powerful tool for studying alterations in cellular components’ biochemical composition and biomolecular secondary structure on a single-cell level. A spectral analysis, complemented by statistics, revealed that the Pd(II) complex considerably affected all major types of macromolecules in HeLa cells and induced structural changes in proteins through an increased formation of cross-β-sheets and causes structural rearrangement in deoxyribonucleic acid (DNA) through potential chromosome fragmentation. Although a certain level of lipid peroxidation was detectable by SR FTIR spectroscopy and confirmed by an analysis of cellular lipids by matrix-assisted laser desorption and ionisation time-of-flight mass spectrometry, the oxidative stress is not a significant mechanism by which Pd(II) expresses the effect on the HeLa cells.

27 March 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
ARAnamarija Abu el Rub
Anamarija Abu el Rub
MNMaja D. Nešić
Maja D. Nešić
TDTanja Ducic
Tanja Ducic
MRMarija Radoičić
Marija Radoičić
MNMirjana Novaković
Mirjana Novaković
MSMilutin Stepić
Milutin Stepić

26 June 2025 in Inorganics
Verified
Journal Article
Open access
PDF file
Vanja RalićVanja Ralić
Vanja Ralić
Katarina DavalievaKatarina Davalieva
Katarina Davalieva
BGBranislava Gemović
Branislava Gemović
MSMilan Sencanski
Milan Sencanski
MNMaja Nešić
Maja Nešić
MPMarijana Petkovic
Marijana Petkovic
This study aims to investigate the effect of the Pd(II) complex on HeLa cells using computational biology and proteomic analysis. [Pd(dach)Cl2]-treated HeLa cells were subjected to comparative proteomics analysis using label-free data-independent liquid chromatography-tandem mass spectrometry (LC-MS/MS). In parallel, the informational spectrum method (ISM) was used to predict potential protein interactors of the [Pd(dach)Cl2] complex in HeLa cells. Proteomics analysis revealed 121 differentially abundant proteins (DAPs). Enrichment analysis of Gene Ontology (GO) annotations revealed ATP hydrolysis and RNA/protein binding as the top molecular functions and RNA splicing and protein–RNA complex organization as the top biological processes. Enrichment analysis of altered canonical pathways pointed out spliceosome and ribosome pathways. The top hub proteins with potential regulatory importance encompassed ribosomal proteins, translational and transcriptional factors, and components of the ribosome assembly machinery. ISM and cross-spectral analysis identified the nucleoplasm and sensor of the single-stranded DNA (SOSS DNA) complex. Proteome analysis showed that [Pd(dach)Cl2] targets proteins involved in ribosomal biogenesis and RNA splicing, whereas theoretical prediction implies also potential effect on p53 signaling pathway, and thus, alterations of the expression of regulatory proteins involved in cell survival and proliferation. These findings underscore the potential of Pd(II) complexes as anti-cancer agents, warranting further exploration and detailed functional validation.

1 January 2023 in Journal of the Serbian Chemical Society
Verified
Journal Article
Open access
PDF file
MSMarinela Sokarda-Slavic
Marinela Sokarda-Slavic
Vanja RalićVanja Ralić
Vanja Ralić
Branislav NastasijevicBranislav Nastasijevic
Branislav Nastasijevic
MMMilica Matijevic
Milica Matijevic
ZVZoran Vujcic
Zoran Vujcic
AMAleksandra Margetic
Aleksandra Margetic
Poly(?-glutamic acid) (PGA), naturally produced by Bacillus species, is a biodegradable, non-toxic, biocompatible and non-immunogenic negatively charged polymer. Due to its properties, it has found various applications in the food, cosmetic and pharmaceutical industries. In this work, Bacillus subtilis 17B was selected as the best PGA producer among fifty wild-types Bacillus strains tested and characterized as a glutamate-independent producer. The production of PGA by the newly identified strain was optimized and increased tenfold using the Box?Behnken experimental design. The purity of PGA after recovery and purification from the fermentation broth was confirmed by SDS- -PAGE followed by methylene blue staining. PGA was characterized by ESI MS and used for the preparation of a new nanocomposite with TiO2. The synthesis of PGA/TiO2 nanocomposite, its structural analysis, and cytotoxic effect on the cervical cancer cell line (HeLa cell) was investigated to determine the potential anti-cancer usage of this newly prepared material. It is encouraging that PGA/TiO2 nanocomposite showed an increased cytotoxic effect compared to TiO2 alone.

Verified
Journal Article
Open access
PDF file
Katarina DavalievaKatarina Davalieva
Katarina Davalieva
Vanja RalićVanja Ralić
Vanja Ralić
GBGjorgji Bozhinovski
Gjorgji Bozhinovski
BGBranislava Gemović
Branislava Gemović
MNMaja Nešić
Maja Nešić
MPMarijana Petkovic
Marijana Petkovic
Carbon dots offer excellent physico-chemical properties and biocompatibility for cancer theranostics systems, either as therapeutic agents themselves, or as potential drug carriers. It is, however, postulated that the drug carrier affects the mechanism of action and intracellular target molecules of a drug. Therefore, in the present study, we systematically evaluated protein alterations in HeLa cervical cancer cells after treatment with sulfur-doped carbon dots (S-CDs). Synchrotron Radiation μFTIR spectroscopy and label-free LC–MS/MS proteomics integrated with bioinformatics were used to assess molecular changes. μFTIR revealed a shift and increased intensity of α-helices, indicating structural changes in proteins as a result of the interaction between S-CDs and cells. Proteomic analysis identified 122 statistically significant (p ≤ 0.05) proteins with increased abundance and 61 with decreased abundance following S-CD exposure, many of which possess high α-helix content, consistent with μFTIR findings. Functional analyses showed that up-regulated proteins were enriched in molecular adaptor, transporter, and transcription regulator activities, particularly those involved in RNA metabolism and translation. Down-regulated proteins were dominated by protein-modifying enzymes and cytoskeletal components. Pathway enrichment analysis indicated alterations in mRNA processing, ribosomal pathways, translation factors, aminoacyl-tRNA biosynthesis, and proteasome degradation. Key hub proteins included ribosomal proteins and translation initiation factors. S-CD treatment led to opposite regulation of many proteins compared to their regulation in untreated HeLa cells including down-regulation of ribosomal proteins (RPS27L, RPS19, and RPS5), aminoacyl-tRNA biosynthesis proteins (IARS1, LARS1, and MARS1), and proteasome degradation proteins (PSMD2, PSMD3, and PSMD11), which aligns with the observed cytotoxic effect of S-CDs on cervical cancer cells. Overall, these results highlight significant proteomic and structural protein changes induced by S-CDs and support their potential for cervical cancer treatment, warranting further investigation of this nanomaterial’s biological applications.